Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
Clinical trial NCT02531906 · COMPLETED
Trial details
- NCT number
- NCT02531906
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-24
- Primary completion
- 2018-06-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.